1. Home
  2. STIM vs FT Comparison

STIM vs FT Comparison

Compare STIM & FT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STIM
  • FT
  • Stock Information
  • Founded
  • STIM 2003
  • FT 1988
  • Country
  • STIM United States
  • FT United States
  • Employees
  • STIM N/A
  • FT N/A
  • Industry
  • STIM Medical/Dental Instruments
  • FT Trusts Except Educational Religious and Charitable
  • Sector
  • STIM Health Care
  • FT Finance
  • Exchange
  • STIM Nasdaq
  • FT Nasdaq
  • Market Cap
  • STIM 224.8M
  • FT 199.8M
  • IPO Year
  • STIM 2018
  • FT N/A
  • Fundamental
  • Price
  • STIM $1.97
  • FT $8.09
  • Analyst Decision
  • STIM Strong Buy
  • FT
  • Analyst Count
  • STIM 2
  • FT 0
  • Target Price
  • STIM $7.00
  • FT N/A
  • AVG Volume (30 Days)
  • STIM 1.6M
  • FT 63.0K
  • Earning Date
  • STIM 11-04-2025
  • FT 01-01-0001
  • Dividend Yield
  • STIM N/A
  • FT 7.85%
  • EPS Growth
  • STIM N/A
  • FT N/A
  • EPS
  • STIM N/A
  • FT N/A
  • Revenue
  • STIM $129,873,000.00
  • FT N/A
  • Revenue This Year
  • STIM $105.70
  • FT N/A
  • Revenue Next Year
  • STIM $11.77
  • FT N/A
  • P/E Ratio
  • STIM N/A
  • FT N/A
  • Revenue Growth
  • STIM 78.61
  • FT N/A
  • 52 Week Low
  • STIM $0.60
  • FT $5.97
  • 52 Week High
  • STIM $5.92
  • FT $7.23
  • Technical
  • Relative Strength Index (RSI)
  • STIM 28.30
  • FT 57.51
  • Support Level
  • STIM $2.01
  • FT $7.92
  • Resistance Level
  • STIM $3.09
  • FT $8.00
  • Average True Range (ATR)
  • STIM 0.25
  • FT 0.07
  • MACD
  • STIM -0.08
  • FT 0.01
  • Stochastic Oscillator
  • STIM 6.88
  • FT 80.00

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

About FT Franklin Universal Trust

Franklin Universal Trust is a closed-end management investment company focused on providing high current income while preserving capital. Its secondary objective is to achieve income growth through dividend increases and capital appreciation. The fund invests in two asset classes: high-yield bonds and utility stocks. It applies fundamental research to build a diversified high-yield bond portfolio and targets utility companies with attractive dividend yields and a history of increasing dividends.

Share on Social Networks: